Ignite Creation Date:
2024-05-06 @ 8:00 AM
Last Modification Date:
2024-10-26 @ 11:55 AM
Study NCT ID:
NCT02648477
Status:
COMPLETED
Last Update Posted:
2024-03-19
First Post:
2016-01-05
Brief Title:
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-05
First Submit QC Date:
January 5 2016
Study First Post Date:
2016-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-20
Last Update Post Date:
2024-03-19
Last Update Post Date Type:
ACTUAL